Richard, C <br/><br/>
Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse.  [electronic resource] 

 -  Bone marrow transplantation  May 1995 
 - 721-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bone Marrow Transplantation--immunology<br/>Child<br/>Child, Preschool<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--administration & dosage<br/>Humans<br/>Killer Cells, Natural--immunology<br/>Leukemia, Myeloid, Acute--immunology<br/>Lymphocyte Activation<br/>Male<br/>Middle Aged<br/>Recombinant Proteins--administration & dosage<br/>Recurrence<br/>Transplantation, Autologous